Vertex Pharmaceuticals Inc / Ma

STOREBRAND ASSET MANAGEMENT AS VRTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/5/2026

Shares

102,567

Value ($000)

45,800

Weight

0.1%

2020 Q1 - 2026 Q1 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/5/2026	45,800	0.1%	102,567	3/31/2026
2025 Q4	5/20/2026	49,676	0.1%	109,573	12/31/2025
2025 Q3	6/3/2026	43,812	0.1%	111,868	9/30/2025
2025 Q2	6/3/2026	48,208	0.1%	108,283	6/30/2025
2025 Q1	6/3/2026	49,025	0.2%	101,120	3/31/2025
2024 Q4	6/17/2026	54,385	0.2%	135,051	12/31/2024
2024 Q3	6/17/2026	65,561	0.2%	140,967	9/30/2024
2024 Q2	6/17/2026	72,783	0.2%	155,281	6/30/2024
2024 Q1	6/17/2026	63,950	0.2%	152,987	3/31/2024
2023 Q4	6/18/2026	64,346	0.2%	158,141	12/31/2023
2023 Q3	6/18/2026	52,937	0.3%	152,231	9/30/2023
2023 Q2	6/18/2026	52,108	0.2%	148,073	6/30/2023
2023 Q1	6/18/2026	52,988	0.3%	168,178	3/31/2023
2022 Q4	6/18/2026	52,380	0.3%	181,383	12/31/2022
2022 Q3	6/18/2026	48,546	0.3%	167,667	9/30/2022
2022 Q2	6/18/2026	39,078	0.2%	138,677	6/30/2022
2022 Q1	6/18/2026	33,857	0.2%	129,735	3/31/2022
2021 Q4	6/18/2026	19,594	0.1%	89,224	12/31/2021
2021 Q3	6/18/2026	17,025	0.1%	93,856	9/30/2021
2021 Q2	6/18/2026	20,386	0.1%	101,105	6/30/2021
2021 Q1	6/18/2026	22,104	0.1%	102,861	3/31/2021
2020 Q4	6/18/2026	29,850	0.2%	126,302	12/31/2020
2020 Q3	6/18/2026	38,139	0.3%	140,156	9/30/2020
2020 Q2	6/18/2026	37,290	0.3%	128,448	6/30/2020
2020 Q1	6/18/2026	25,560	0.3%	107,419	3/31/2020